Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Eagan

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Neurosurgery|December 1, 1981
Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) studyE R Laws, D A Cortese, J H Kinsey, et al.
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
Cancer Treatment Reports|August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lungJ C Britell, R T Eagan, J N Ingle, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
Neurology|July 1, 1987
Delayed leukoencephalopathy in survivors with small cell lung cancerN K So, B P O'Neill, S Frytak, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Oncology|January 1, 1980
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancerJ Rubin, D A Decker, D L Ahmann, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Neurosurgery|December 1, 1981
Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) studyE R Laws, D A Cortese, J H Kinsey, et al.
Cancer Treatment Reports|January 1, 1977
Phase II studies of polychemotherapy regimens in small cell lung cancerR T Eagan, D T Carr, R E Lee, et al.
Cancer Treatment Reports|August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lungJ C Britell, R T Eagan, J N Ingle, et al.
Cancer Treatment Reports|November 1, 1981
Phase I and pharmacokinetic studies of DONJ S Kovach, R T Eagan, G Powis, et al.
Neurology|July 1, 1987
Delayed leukoencephalopathy in survivors with small cell lung cancerN K So, B P O'Neill, S Frytak, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Oncology|January 1, 1980
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancerJ Rubin, D A Decker, D L Ahmann, et al.
Pageof 11